Iradimed (IRMD) EBT Growth (1y) (2014 - 2026)
Powered by 
Analysis
Iradimed (IRMD) EBT Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -29.12% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 26.74% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 35.87% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 53.94% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 12.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.89% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -123.12% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 31.69% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 17.94% |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | -5.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.99% |
| Mar 31, 2026 | 30.68% |
| Dec 31, 2025 | 22.80% |
| Sep 30, 2025 | 13.70% |
| Jun 30, 2025 | 16.87% |
| Mar 31, 2025 | 13.38% |
| Dec 31, 2024 | 11.66% |
| Sep 30, 2024 | 0.15% |
| Jun 30, 2024 | 18.32% |
| Mar 31, 2024 | 20.55% |
| Dec 31, 2023 | 20.79% |
| Sep 30, 2023 | 51.23% |
| Jun 30, 2023 | 26.77% |
| Mar 31, 2023 | 42.15% |
| Dec 31, 2022 | 51.07% |
| Sep 30, 2022 | 36.96% |
| Jun 30, 2022 | 125.03% |
| Mar 31, 2022 | 72.75% |
| Dec 31, 2021 | 368.52% |
| Sep 30, 2021 | 289.62% |